RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Genomma Lab Internacional SAB de CV Stock

Genomma Lab Internacional SAB de CV ROA 2024

Genomma Lab Internacional SAB de CV ROA

0.05

Ticker

LABB.MX

ISIN

MX01LA010006

WKN

A0Q4TC

In 2024, Genomma Lab Internacional SAB de CV's return on assets (ROA) was 0.05, a -18.63% increase from the 0.06 ROA in the previous year.

Genomma Lab Internacional SAB de CV Aktienanalyse

What does Genomma Lab Internacional SAB de CV do?

Genomma Lab Internacional SAB de CV is a leading Mexican company that specializes in the manufacturing and marketing of branded products in the health, beauty, and hygiene sector. The company was founded in 1996 by Rodrigo Herrera as a family business that initially focused on the sale of hemorrhoid creams. Over the years, however, the company has evolved into a global market leader and now distributes a wide range of products in more than 20 countries worldwide. Genomma Lab's business model is based on the development, production, and marketing of its own branded products, which are sold through a broad and diverse network of distribution channels, including drugstores, supermarkets, pharmacies, and online shops. Genomma Lab has three main business segments: Consumer Health, Personal Care, and Pharmaceuticals. The Consumer Health segment includes products such as creams, ointments, tablets, and capsules for the treatment of conditions such as fungal infections, itching, pain, and inflammation. Some of the most well-known brands in this segment are Tío Nacho, Cicatricure, Asepxia, and Siluet 40. Personal Care offers a wide range of beauty products, including hair care products, skin care products, deodorants, and dental care products. Some of the most notable brands in this segment are Goicoechea, Genomma Lab Originals, and Tugaboos. Pharmaceuticals is Genomma Lab's third business segment and includes prescription medications that are prescribed by doctors to treat a variety of conditions. However, this segment is still relatively small and accounts for only a small portion of the overall business. Every year, Genomma Lab introduces numerous new products to the market and continually works to expand and improve its product lines. The company has a strong focus on innovation and invests continuously in research and development to develop new and more effective products and optimize the effectiveness of its existing products. Genomma Lab has also made a name for itself by designing innovative marketing strategies and promoting its products through aggressive advertising campaigns and sales promotion initiatives. In fact, the company has conducted some of the most well-known advertising campaigns in the Mexican television landscape, and its products are often promoted by well-known personalities and celebrities. In summary, Genomma Lab is a leading company in the health, beauty, and hygiene sector, specializing in the manufacturing and marketing of branded products. The company has a broad and diverse network of distribution channels and utilizes aggressive marketing strategies to promote and sell its products. The company has experienced impressive growth in recent years and is expected to continue growing and expanding in the future. Genomma Lab Internacional SAB de CV ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Genomma Lab Internacional SAB de CV's Return on Assets (ROA)

Genomma Lab Internacional SAB de CV's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Genomma Lab Internacional SAB de CV's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Genomma Lab Internacional SAB de CV's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Genomma Lab Internacional SAB de CV’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Genomma Lab Internacional SAB de CV stock

What is the Return on Assets (ROA) of Genomma Lab Internacional SAB de CV this year?

The Return on Assets (ROA) of Genomma Lab Internacional SAB de CV is 0.05 undefined this year.

What was the ROA of Genomma Lab Internacional SAB de CV compared to the previous year?

The ROA of Genomma Lab Internacional SAB de CV has increased by -18.63% compared to the previous year.

What consequences do high ROA have for investors of Genomma Lab Internacional SAB de CV?

A high ROA is advantageous for investors of Genomma Lab Internacional SAB de CV, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Genomma Lab Internacional SAB de CV?

A low ROA can be unfavorable for investors of Genomma Lab Internacional SAB de CV as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Genomma Lab Internacional SAB de CV affect the company?

An increase in ROA of Genomma Lab Internacional SAB de CV can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Genomma Lab Internacional SAB de CV impact the company?

A reduction in the ROA of Genomma Lab Internacional SAB de CV can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Genomma Lab Internacional SAB de CV?

Some factors that can influence the ROA of Genomma Lab Internacional SAB de CV include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Genomma Lab Internacional SAB de CV important for investors?

The ROA of Genomma Lab Internacional SAB de CV is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Genomma Lab Internacional SAB de CV take to improve ROA?

To improve ROA, Genomma Lab Internacional SAB de CV can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Genomma Lab Internacional SAB de CV pay?

Over the past 12 months, Genomma Lab Internacional SAB de CV paid a dividend of 0.59 MXN . This corresponds to a dividend yield of about 2.29 %. For the coming 12 months, Genomma Lab Internacional SAB de CV is expected to pay a dividend of 0.63 MXN.

What is the dividend yield of Genomma Lab Internacional SAB de CV?

The current dividend yield of Genomma Lab Internacional SAB de CV is 2.29 %.

When does Genomma Lab Internacional SAB de CV pay dividends?

Genomma Lab Internacional SAB de CV pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Genomma Lab Internacional SAB de CV?

Genomma Lab Internacional SAB de CV paid dividends every year for the past 7 years.

What is the dividend of Genomma Lab Internacional SAB de CV?

For the upcoming 12 months, dividends amounting to 0.63 MXN are expected. This corresponds to a dividend yield of 2.46 %.

In which sector is Genomma Lab Internacional SAB de CV located?

Genomma Lab Internacional SAB de CV is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genomma Lab Internacional SAB de CV kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genomma Lab Internacional SAB de CV from 9/17/2024 amounting to 0.2 MXN, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Genomma Lab Internacional SAB de CV pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of Genomma Lab Internacional SAB de CV in the year 2023?

In the year 2023, Genomma Lab Internacional SAB de CV distributed 0.763 MXN as dividends.

In which currency does Genomma Lab Internacional SAB de CV pay out the dividend?

The dividends of Genomma Lab Internacional SAB de CV are distributed in MXN.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Genomma Lab Internacional SAB de CV

Our stock analysis for Genomma Lab Internacional SAB de CV Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genomma Lab Internacional SAB de CV Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.